Why is Astec Lifescienc falling/rising?

As of 30-Jun, Astec Lifesciences Ltd is experiencing a decline in its stock price, currently at Rs 927.95, reflecting a decrease of Rs 15.05 or 1.6%. The stock has underperformed its sector by 2.89% today and has been on a downward trend for the last two days, with a total loss of 5.89% during this period. Despite trading above its moving averages, the stock's delivery volume has significantly decreased, indicating falling investor participation. Additionally, the company has reported negative results for the last four consecutive quarters, with substantial declines in net sales and profits, which raises concerns about its long-term fundamental strength. While there has been a slight increase in promoter confidence with a 4.12% stake increase, the overall financial performance remains weak, contributing to the stock's recent decline.
In the broader market context, Astec Lifesciences has shown a remarkable short-term return of 21.71% over the past week, significantly outperforming the Sensex, which has only increased by 2.09%. However, this positive short-term performance contrasts sharply with the stock's long-term trajectory, where it has underperformed the benchmark over the past year and three years, with returns of -28.68% and -49.06%, respectively. This consistent underperformance against the benchmark, coupled with weak financial indicators and a high debt-to-EBITDA ratio, suggests that while there may be short-term fluctuations, the overall outlook for Astec Lifesciences remains challenging.